15
total announcements
524768.BO · 15 min delayed
Emmessar Biotech & Nutrition Ltd
Emmessar Biotech & Nutrition Ltd has published its audited financial results for the quarter ended September 30, 2026, in the Free Press Journal and Nav Shakti newspapers, as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Emmessar Biotech & Nutrition Ltd
Emmessar Biotech & Nutrition Ltd has announced its unaudited financial results for the quarter ended September 30, 2026, showing revenue from operations at Rs. 10.92 lakhs and profit from operations before tax at Rs. 17.26 lakhs.
Emmessar Biotech & Nutrition Ltd
Emmessar Biotech & Nutrition Ltd has announced its unaudited financial results for the quarter ended September 30, 2026, with revenue from operations at Rs. 10.92 crores and profit from operations before tax at Rs. 17.26 crores.
Emmessar Biotech & Nutrition Ltd
Emmessar Biotech & Nutrition Ltd has scheduled a Board Meeting on October 31, 2026, to consider and approve unaudited Financial Results for the quarter ended September 30, 2026.
Emmessar Biotech & Nutrition Ltd
Emmessar Biotech & Nutrition Ltd has issued a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialization of securities for the quarter ended 30th September, 2026.
Emmessar Biotech & Nutrition Ltd
Emmessar Biotech & Nutrition Ltd has published a newspaper advertisement informing shareholders about a special window for re-lodging transfer requests of physical shares, as per SEBI circulars.
Emmessar Biotech & Nutrition Ltd
Emmessar Biotech & Nutrition Ltd has announced the closure of its trading window from October 1, 2026, until 48 hours after the release of its Q2 FY2026-27 financial results.
Emmessar Biotech & Nutrition Ltd
Emmessar Biotech & Nutrition Ltd has announced the Scrutinizers Report on remote e-voting and e-voting conducted at the 34th Annual General meeting (AGM) of the Company held on September 29, 2026. The resolutions passed include the adoption of Audited Financial Statements for the Financial Year ended March 31, 2026, the re-appointment of Mr. Jeyavel Balaiah Nadar as Director, and the re-appointment of Mr. Srinivasa Raghavan Mathurakavi Ayyangar as Managing Director for a further period of 5 years.
Emmessar Biotech & Nutrition Ltd
Emmessar Biotech & Nutrition Ltd held its 34th Annual General Meeting (AGM) on September 29, 2026, through video conferencing. The meeting approved the audited financial statements for the FY ended March 31, 2026, and re-appointed Mr. Srinivasa Raghavan Mathurakavi Ayyangar as Managing Director for a further period of 5 years.
Emmessar Biotech & Nutrition Ltd
Emmessar Biotech & Nutrition Ltd has announced a newspaper advertisement for its 34th Annual General Meeting (AGM) to be held on September 29, 2026, through video conferencing.
Emmessar Biotech & Nutrition Ltd
Emmessar Biotech & Nutrition Ltd has announced its unaudited consolidated financial results for the quarter ended June 30, 2026, showing a net profit of Rs. 629.49 lakhs and a total income from operations of Rs. 4,277.16 lakhs.
Emmessar Biotech & Nutrition Ltd
Emmessar Biotech & Nutrition Ltd has announced its unaudited financial results for the quarter ended June 30, 2026. The company has provided the facility for shareholders to exercise their right to vote at the Annual General Meeting (AGM) by electronic means. The results have been reviewed by the Audit Committee and approved by the Board of Directors.
Emmessar Biotech & Nutrition Ltd
Emmessar Biotech & Nutrition Ltd announced unaudited financial results for the quarter ended June 30, 2026, with the Board of Directors approving the results and the Audit Committee reviewing them. The company will hold its 34th Annual General Meeting through video conferencing, with e-voting facilities available for members.
Emmessar Biotech & Nutrition Ltd
Emmessar Biotech & Nutrition Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 07/08/2026 to consider and approve unaudited Financial Results for the quarter ended June 30, 2026.
Emmessar Biotech & Nutrition Ltd
Emmessar Biotech & Nutrition Ltd has published a newspaper advertisement informing shareholders regarding the special window for re-lodgement of transfer requests of physical shares, as per SEBI Circulars.